Global

Sep 19, 2019

Royal Philips sells its remaining shares in Signify for total proceeds of approximately EUR 357 million

Amsterdam, The Netherlands – Today, Koninklijke Philips N.V. (“Royal Philips”) announces that it has successfully completed the accelerated bookbuild offering to institutional investors of 13.8 million shares in Signify N.V. (“Signify”) at a price of EUR 25.90 per share (the “Offering”), realizing total proceeds of approximately 357 million. 

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 80,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Click here to read moreClick here to read less

Topics

Contacts

Ben Zwirs

Ben Zwirs

Philips Global Press Office

Tel: +31 6 1521 3446

You are about to visit a Philips global content page

Continue

Press releases

Get our press releases by e-mail

You are about to visit a Philips global content page

Continue

Share on social media

  • https://www.philips.com/a-w/about/news/archive/standard/news/press/2019/20190919-royal-philips-sells-its-remaining-shares-in-signify-for-total-proceeds-of-approximately-eur-357-million.html Link copied

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.